1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow ABPA: new trials by email Literature Review of ABPA trials Research Report on ABPA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA Fasenra, 30 Mg/mL Subcutaneous Solution - ABPA, Severe Asthma | Phase 4 | Withdrawn | Baylor Research Institute | 2019-12-23 | 2022-02-01 |
Aspergillosis, Allergic Bronchopulmonary (1) · Asthma (1)
Aspergillosis (1) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Fungal (1) · Lung Diseases, Obstructive (1) · Mycoses (1) · Pulmonary Aspergillosis (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
benralizumab (1)
United States (1)